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PURPOSE. To compare the capability of indocyanine green angiography (ICGA) and optical
coherence tomography angiography (OCTA) in detecting choroidal neovascularization (CNV).
METHODS. In this prospective study, patients with CNV detected with fluorescein angiography
(FA) underwent ICGA and OCTA, spectral domain OCT (SD-OCT), and infrared or fundus
color photographs. CNV lesions were outlined on ICGA and OCTA images, and the
composition and size of the CNV was documented.
RESULTS. One hundred eighty-two eyes were included. With ICGA, well-defined lesions were
observed in 37.9%, partly defined in 44.5%, and undefined in 17% of eyes. On OCTA, well-
defined, partly defined, and undefined vessels were observed in 53.8%, 27.5%, and 18.7% of
eyes, respectively. There was a good correlation between CNV size measured with the two
instruments (r ¼ 0.84). However, OCTA underestimated CNV area by about 4.5% (slope
coefficient with linear regression: 0.55, 95% confidence interval [CI]: 0.46 to 0.65; intercept:
0.27, 95% CI: 0.2 to 0.56). On ICGA, CNV composition was capillary in 28%, mature in
14.3%, and mixed (capillary and major neovascular complex) in 57.7% of eyes. Similarly,
OCTA revealed capillary, mature, and mixed CNV in 28.9%, 15.9%, and 55.5% of eyes,
respectively.
CONCLUSIONS. OCTA provides the clinician the ability to perform precise structural and
vascular assessment of CNV noninvasively. Our study is, to our knowledge, the largest OCTA
analysis to date of CNV secondary to neovascular AMD analyzed simultaneously by ICGA and
OCTA.
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CNV represents the late stage of AMD. These abnormalblood vessels typically sprout from the choriocapillaris and
can penetrate Bruch’s membrane into the space beneath the
RPE (type 1 CNV) or the subretinal space (type 2 CNV). In
some eyes, neovascularization seems to begin from the retinal
vessels, induces a pigment epithelium detachment, and finally
creates anastomosis with choroidal vasculature (retinal angio-
matous proliferation, also called type 3 CNV).1–3
Early diagnosis and characterization of choroidal neovascu-
larization (CNV) are crucial for initiating and guiding treatment
with an intravitreal inhibitor of VEGF to prevent progressive
and invalidating vision loss.4
The current gold standard for CNV diagnosis is fluorescein
angiography (FA).5–7 FA uses intravenous fluorescein injection
to visualize CNV and to identify the patterns of dye leakage that
characterize the different CNV types.8–10
Nevertheless, many studies have reported that indocyanine
green angiography (ICGA) can improve the ability to detect
CNV in patients with neovascular AMD compared to FA alone,
particularly when type 1 CNV is present.11,12 In fact,
indocyanine green (ICG) angiograms obtained using both the
scanning laser ophthalmoscope and digital video-angiography
enabled the visualization of 55% and 61% of CNV, respectively,
in cases where the CNV could not be determined with FA.13–15
Detection of type 2 CNV on ICGA reportedly approaches 100%
in patients with neovascular AMD.16
A new imaging technology, optical coherence tomography
angiography (OCTA), has recently been developed and allows
for new insights in the noninvasive visualization of normal and
pathologic vascularization. This imaging technique detects
erythrocyte movement by comparing sequential OCT B-scans
at a given cross section. OCT angiograms are coregistered with
OCT B-scans from the same area, allowing for simultaneous
visualization of structure and blood flow.17–20
OCTA allows for the visualization of both the inner and
outer retinal vascular plexi, as well as the choriocapillaris layer,
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without the need for dye injection and provides a segmentation
of the different layers using the en face OCT modality.21
The aim of this study was to compare the capability of ICGA
and OCTA in detecting the vascular network in active CNV
secondary to wet AMD. We also performed a qualitative
analysis of the characteristics and composition of the
neovascular lesions.
METHODS
This study was approved by the Institutional Review Board of
the PTV Foundation, and informed consent was obtained from
patients before examination. The research adhered to the
tenets of the Declaration of Helsinki.
In this prospective study, subjects were enrolled between
February 2015 and June 2016 at four different retina centers in
Italy, including the Retina Service of the PTV Foundation in
Rome; the University Eye Clinic in Torino, the Sant’Orsola
Hospital in Bologna, and the IRCCS Bietti Eye Foundation in
Rome.
Patients affected by AMD with active CNV detected with FA
were further studied with ICGA (Spectralis; Heidelberg
Engineering, Heidelberg, Germany) and OCTA (AngioVue
Imaging System; Optovue, Inc., Fremont, CA, USA), spectral-
domain (SD-OCT) (Spectralis; Heidelberg Engineering), and
infrared (IR) images or fundus color photographs (FP) (Topcon
TRC IA; Topcon, Tokyo, Japan). Both na¨ıve patients and
patients with recurrences were included. The exams were
performed on the same day or within 1 week. Best-corrected
visual acuity (BCVA) was measured with Early Treatment
Diabetic Retinopathy Study charts before dilation of the pupils.
The AngioVue imaging system used to obtain OCTA images
has an A-scan rate of 70,000 scans per second, using a light
source centered on 840 nm and a bandwidth of 50 nm. Each
OCTA volume contains 304 3 304 A-scans with two
consecutive B-scans captured at each fixed position before
proceeding to the next sampling location. Split-spectrum
amplitude-decorrelation angiography (SSADA) was used to
extract the OCTA information. Each OCTA volume is acquired
in 3 seconds, and two orthogonal OCTA volumes were
acquired in order to perform motion correction to minimize
motion artifacts arising from microsaccades and fixation
changes. Angiography information displayed is the average of
the decorrelation values when viewed perpendicularly through
the thickness being evaluated.
We used a research version of the AngioVue OCTA
software.21,22
Orthogonal registration and merging of two consecutive
scan volumes were used to obtain 3 3 3-mm and 6 3 6-mm
OCTA volumes of both eyes of each patient. Both 333-mm and
63 6-mm OCTA volumes used a 3043 304 scanning pattern.
Standard OCT B-scans were performed to confirm the
intraretinal or subretinal fluid presence confirming the lesion
activity.
The OCTA software was used to delineate a region of
interest with a slab thickness of 30 lm. The software did not
allow modification of the segmentation curve of the inner or
outer retina; it only allowed moving the original automated
segmentation lines up or down. We used the ‘‘outer retina’’
segmentation, which in the software is by default automatically
based on the contour of the Bruch’s membrane. Therefore, we
chose to locate the outer boundary directly anterior to Bruch’s
membrane to minimize the amount of choroidal vasculature
included in the slab. The inner boundary was set to contain the
innermost region suspicious of a CNV, as demonstrated in the
B-scan.
The built-in automatic artifact removal tool was used to
remove retinal vessel shadowing from the en face flow image.
This function allowed us to subtract vessels located above the
inner border (inner retina vessels) from the outer retina OCTA
image.
The 333-mm OCTA images were used primarily to evaluate
each eye. In cases where the 33 3-mm OCTA image showed a
CNV that extended beyond the image border, a 6 3 6-mm
OCTA image was used so that the entire borders of the CNV
could be evaluated. There were no lesions extended beyond
the 6 3 6 area. In order to measure the CNV lesion size on
OCTA, we used the imaging system provided by AngioVue
software (AngioVue, RTVue XR Avanti; Optovue, Inc.), by
selecting ‘‘Flow Area’’ function.
ICG angiograms were acquired (Spectralis) using a 30-
degree field and art mode of 15 images. Early-to-mid-phase ICG
angiograms of the detailed vascular structure of the CNV were
screened, and the best angiograms were used for image
analysis. To measure the CNV lesion size on ICGA we used the
area-measuring software provided by Spectralis.
Appearance of CNV on both ICGA and OCTA images was
classified as well-defined (the CNV network is entirely visible in
all its extension, and all the borders are evident); partly defined
(the CNV network is not visible in all its extension and some
borders are missing); or undefined (it is not possible to
differentiate the CNV network from the choroidal background
signal).
When detectable either on ICGA or OCTA, capillary and
arteriovenular components of CNV were identified in order to
classify the lesion as follows:
1. Capillary (typically spoke wheel or sea fan–shaped
lesions composed by tiny curled vessels with anastomot-
ic connections at the CNV border)
2. Mixed (capillary plus mature vessels)
3. Mature (arteriovenular or major neovascular complex
[MNC] made by large-diameter dendritic trunks with a
negligible or absent capillary component)
4. RAP (focal anastomotic neovascular complex arising
from the deep retina capillary plexus)
5. Polypoidal choroidal vasculopathy (PCV; presence of
single or multiple focal nodular ectatic lesions at the
edge of a sub-RPE neovessel network).
Subretinal (SRF) and intraretinal fluid (IRF) was determined
to be present or absent using the correlated OCT B-scans. SD-
OCT B-scans were also analyzed to detect the presence of
fibrovascular pigment epithelium detachment (PED) or serous
PED.
FP or IR photographs were evaluated for the presence of
intra- or subretinal hemorrhages and fibrosis.
All the images (OCTA, B-scan SD-OCT, FA, ICGA, FP, and IR)
were evaluated independently by two trained readers (CME,
MP) from the University Eye Clinic of Torino and the IRCCS
Bietti Eye Foundation, respectively, to confirm the diagnosis
and to define the characteristics of the CNV. The readers were
masked, and in particular, they first evaluated the B-scan SD-
OCT, FA, ICGA, FP, and IR. OCTA images were evaluated
separately without knowing the corresponding ICGA in order
to decrease possible bias. In case of discordance the
measurements were reevaluated by a third retinal specialist
(FR).
In order to compare the performance of ICGA and OCTA in
defining CNV borders (three categories), we used asymptotic
symmetry and marginal homogeneity tests, which are suitable
for K3K tables where there is a one-to-one matching of cases
classified by means of ordered variables. We used ordinal
logistic regression to investigate covariates associated with
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border definition, and we used a v2 test to compare
frequencies in subgroups of unordered categories.
We used linear regression to investigate the need for
calibration of lesion size with OCTA as compared to ICGA. We
compared a number of clinical characteristics in capillary
OCTA lesions versus other types of lesions using a v2 test.
RESULTS
Study Population
One hundred eighty-two eyes of 182 consecutive patients with
wet AMD were enrolled in this study. All were Caucasian with a
mean age of 74 6 3.8 years (range, 58–89). There were 111
(61%) women. Each patient underwent BCVA examination, FP
or IR photograph, FA, ICGA, SD-OCT, and OCTA examination
on the same day or within 1 week. No adverse effects related to
the procedures (i.e., dye injection) were reported.
One hundred five of 182 (58%) eyes were na¨ıve CNV, while
77 of 182 (42%) eyes presented recurrent CNV with active
leakage on FA or IRF or SRF on B-scan SD-OCT. Mean BCVA was
20/50 Snellen equivalent (range 20/20–20/400). Hemorrhages
and fibrosis were present in 45 of 182 (24.7%) and 61 of 182
(33.5%) eyes, respectively. On FA, most of the CNV were type 1
(73%), followed by type 2 (27%). ICGA confirmed type 3 or
RAP and PCV lesions in 14 (7.7%) and 12 (6.6%) eyes,
respectively. B-scan SD-OCT showed the presence of SRF and
IRF in 122 of 182 (67%) and 75 of 182 (41.2%) eyes,
respectively. Fibrovascular PED was detected in 102 of 182
(56%) eyes and serous PED in 53 of 182 (29.1%) eyes.
Definition of CNV Borders
When analyzed with ICGA, well-defined lesions were observed
in 37.9% (69/182) of eyes, partly defined in 44.5% (81/182) of
eyes, and undefined in 17% (32/182) of eyes. On OCTA images,
well-defined, partly defined, and undefined vessels were
observed in 53.8% (98/182), 27.5% (50/182), and 18.7% (34/
182) of eyes, respectively. The intra/subretinal fluid was
minimal or absent in all eyes and could not influence the
OCTA flow images. The PCV lesions identified on ICGA were
not visible on the choroidal background and therefore were
classified as ‘‘undefined’’ on OCTA.
Figure 1 shows the agreement of ICGA and OCTA in
defining CNV borders in 182 patients with complete data.
More than half of the CNVs were well-defined with OCTA, as
compared to one-third with ICGA. Overall, there was only
moderate agreement between the two techniques (j ¼ 0.40).
Both the symmetry test and the marginal homogeneity test
were highly significant (P < 0.01), thus indicating a difference
in the degree of border definition between the two tests.
Specifically, the largest contribution to the symmetry v2 was
given by the fact that CNVs that were well-defined in OCTA
versus partly defined in ICGA were about four times that of
those well-defined in ICGA and partly defined in OCTA. Similar
ratios of asymmetry were found in other matched cells.
Asymmetry remained highly significant when the analysis
was restricted to 133 type 1 CNVs. A similar subanalysis was
not possible on 46 type 2 CNVs, 14 type 3 CNVs, and 12 PCVs
due to the limited sample size.
CNV Size
Figure 2 shows the relationship between CNV size (area in
square millimeters) with OCTA as compared to ICGA, including
lesions that were well-defined with both techniques (n ¼ 59).
There was a good correlation between CNV size measured with
the two instruments (r ¼ 0.84). However, as seen in Figure 2,
OCTA underestimated CNV area by about 4.5% (slope
coefficient with linear regression: 0.55, 95% CI: 0.46 to 0.65;
intercept: 0.27, 95% CI:0.2 to 0.56), suggesting the need for a
calibration formula. No difference in size by OCTA CNV type
was detected using a regression model (P ¼ 0.507).
Characteristics of CNV Lesions
When analyzed with ICGA, CNV composition results were
capillary in 28% (51/182) of eyes, mature in 14.3% (26/182) of
eyes, and mixed (capillary and MNC) in 57.7% (105/182) of
eyes. OCTA images revealed capillary CNV in 28.9% (52/182)
of eyes, mature in 15.9% (29/182) of eyes, and mixed in 55.5%
(101/182) of eyes.
We explored the characteristics of different CNV types in
OCTA, considering clinical, FA, and OCTA margin definition,
after excluding type 3 CNVs (n ¼ 14). For this purpose, we
compared capillary CNVs to other types, thus trying to
FIGURE 1. CNV borders defined by ICGA (left) and OCTA (right). The figure shows agreement of ICGA and OCTA in defining CNV borders in 182
patients. More than half of the CNVs were well-defined with OCTA (53.80%), as compared to one-third with ICGA (37.90%) (P¼0.03). Partly defined
CNVs were identified mostly with ICGA (44.50%) rather than with OCTA (27.50%) (P ¼ 0.02). No statistical significant difference was found for
undefined CNV with ICGA and OCTA (17% and 18.70%, respectively). NS, nonstatistically significant.
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characterize lesions that did not have mature choroidal vessels
on OCTA (Table). Compared to other CNV types, capillary
lesions were more likely to be type 2 CNV and to have well-
defined OCTA margins, while they were less likely to show
fibrovascular PED (Figs. 3, 4).
Factors Associated With Border Definition With
ICGA and OCTA
We explored the characteristics associated with well-defined
borders separately for ICGA and OCTA. Results were consistent
using both forward and backward ordinal logistic regression.
We found that better defined borders with ICGA were more
often found in na¨ıve (odds ratio [OR] 2.1, P¼0.023) and type 2
(OR 2.8, P ¼ 0.003) lesions and less often in lesions showing
staining with borderline statistical significance (OR 0.52, P ¼
0.065). On the other hand, better defined lesions in OCTA
were more likely type 2 CNV (OR 2.6, P¼ 0.010) and capillary
CNV rather than mixed CNV (OR 3.0, P ¼ 0.003).
DISCUSSION
Presented in this article is a large qualitative study that
investigated OCTA imaging using a commercially available
OCTA system.
While FA remains the gold standard in the initial diagnosis
of neovascular AMD,7,23,24 and while SD-OCT has become an
indispensable technique in the management of wet AMD due
to its capability to assess the presence of intra/subretinal fluid
accumulation,25 ICGA is useful in defining the subtypes and
the exact area of CNV.11 However, ICGA is invasive, and the
dye injection, although considered safe, has risks ranging from
discomfort and nausea to, in rare cases, anaphylaxis. In
addition, the technique is expensive (the best results are
achievable only by scanning laser devices) and time-consum-
ing, requiring up to 10 minutes of imaging time, which can
limit its routine use in a busy clinical setting.26,27
The OCTA is a noninvasive, rapid technique for imaging
CNV via semiautomated segmentation of the outer retina and
subretinal or sub-RPE space from a volumetric OCTA data set.
Moreover, corresponding OCT B-scans obtained concurrently
were useful in identifying subretinal fluid and other anatomic
nonvascular features that were also relevant in the diagnosis of
CNV and disease activity.
OCT angiography provides a unique opportunity to directly
visualize and study neovascular membranes and their micro-
vascular details in both type 1 and type 2 AMD complexes,
which are otherwise only visible with ICGA.28
We were able to collect 182 eyes with AMD and type 1, type
2, type 3, or PCV neovascularization and to carefully study,
characterize, and analyze the borders, the size, and the
morphology of the vascular complex with different imaging
modalities.
In this study we demonstrated a moderate agreement
between ICGA and OCTA in defining CNV borders, with higher
percentage of well-defined lesion borders detected by OCTA.
This might be due primarily to the nature of the CNV lesion. In
fact, almost two-thirds of the lesions were type 1 CNV located
below the RPE. The amount of subretinal fluid was minimal
and less likely to influence the border definition on OCTA. The
use of SD-OCTA might represent another factor influencing the
quality of imaging of CNV mostly when compared to swept-
source OCTA (SS-OCTA).
Previous studies showed similar results when comparing
OCTA with FA. In particular, de Carlo et al.20 reported a
sensitivity and specificity of CNV detection by OCTA of 50%
and 91%, respectively. Also Kuehlewein et al.28 reported a large
series of type1 CNV detected by OCTA. They were able to
FIGURE 2. Relationship between CNV size with OCTA as compared to
ICGA. There was a good correlation between CNV size (area in square
millimeters) measured with the two instruments (r ¼ 0.84). However,
OCTA underestimated CNV area by about 4.5% (slope coefficient with
linear regression: 0.55, 95% CI: 0.46 to 0.65; intercept: 0.27, 95% CI:
0.2 to 0.56). No difference in size by OCTA CNV type was detected (P
¼ 0.507). Different marker symbols are displayed for OCTA CNV
subtypes: capillary (dark circle), capillary þ MNC (gray diamond),
mixed (empty square); the dotted line presents the equivalence line,
where CNV size values (in square millimeters ) with ICGA and OCTA
are equivalent. The solid line presents the linear fit as predicted in a
regression model and shows that ICGA overestimates size with respect
to OCTA.
TABLE. Comparison of Morphologic CNV Characteristics, as Assessed
With Multimodal Imaging, by OCTA Subtype
Morphologic
Characteristics
Capillary, % MNC or Mixed, %
P Valuen ¼ 128 n ¼ 51
Type 2 (vs. others) 39 20% 0.003*
Leakage (FA) 88 79 0.144
Staining (FA) 19 31 0.115
Fibrovascular PED 33 65 <0.001*
Serous PED 23 32 0.256
Blood 29 23 0.415
Fibrosis 25 37 0.124
Subretinal fluid 63 68 0.517
Intraretinal fluid 50 38 0.128
Well-defined OCTA
margins
75 45 <0.001*
Distinct morphologic features are compared between capillary
lesions and other choroidal neovascular membranes that did not have
mature choroidal vessels on OCTA. Compared to other CNV types,
capillary lesions were more likely to be type 2 CNV and to have well-
defined OCTA margins, while they were less likely to show PED.
* Statistically significant (P < 0.01).
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noninvasively assess the structure and vascular composition of
neovascular membrane secondary to wet AMD.
Other studies, using different devices and different decor-
relation algorithms (SD-OCT or swept-source OCT, Spectralis
OCTA prototype) reported that the sensitivity of the OCTA in
detecting choroidal neovascular lesions ranged from 50% to
100%.20,21,25,29
In particular, Jia et al.21 reported five cases of CNV and
compared them with normal eyes using OCTA from a
prototype SS-OCT. Their prototype system operated at
100,000 A-scans per second to acquire 200 3 200 A-scans in
3.5 seconds. Orthogonal registration and merging of four scans
were then used to create 33 3-mm OCTA images.
The AngioVue system used in this study operates at 70,000
A-scans per second to obtain 3043 304 A-scans in 2.6 seconds,
merging and registering two consecutive scans to achieve 33
3-mm or 6 3 6-mm OCTA images. Therefore, the AngioVue
system with the SSADA algorithm, although using a lower
scanning speed, allows for shorter imaging time than the SS-
OCT prototype thanks to the lower number (two) of repeat B-
scans required at each location.
A recent study using the Spectralis prototype reported the
correspondence between OCTA and traditional multimodal
imaging techniques ranged between 94.9% and 90.5% con-
cerning treatment decision in a series of eyes with CNV.25
Our findings regarding the size of the CNV demonstrated a
good correlation between the areas measured with the two
instruments, despite the need for a calibration formula. In fact,
ICGA overestimated the CNV area by 30%, probably due to the
different acquisition field of 303 30 degrees and 33 3 mm for
the ICGA and OCTA, respectively, as well as the different
software used to measure the CNV size. A recent paper
compared the measurement of type 1 CNV with ICGA and
OCTA. Costanzo et al.30 reported that the lesion size in OCTA
FIGURE 3. Type 1 CNV in the right eye of an 81-year-old man. (A) OCT B-scan and corresponding IR image shows a subfoveal vascularized PED with
small subretinal fluid. (B) FA evidences an irregular iperfluorescence in the macular area, that (C) corresponds to CNV evident on ICGA. (D) OCTA
demonstrates the CNV with well-defined borders and mixed composition.
FIGURE 4. Type 2 CNV in the left eye of a 75-year-old man. (A) OCT B-scan and corresponding IR image shows a juxtafoveal iperreflective area and
adjacent subretinal fluid. (B) FA evidences a juxtafoveal CNV with well-defined borders. (C) Corresponding ICGA confirms the presence of the well-
defined CNV. (D) OCTA demonstrates the capillary CNV with well-defined borders.
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measured in the choriocapillaris segmentation is significantly
smaller than the lesion size measured in both intermediate and
late frames of ICGA. Moreover, recent papers reported
different CNV size when measured with SS-OCTA or SD-OCTA
and compared to ICGA. In particular, Roisman et al.31
demonstrated that CNV size on SS-OCTA images were
comparable to the size of the plaque identified on ICGA, while
Miller et al.32 showed a larger CNV area when imaged with SS-
OCTA than with SD-OCTA.
Analysis of CNV composition revealed a similar capability to
detect capillary pattern, as well as mixed and mature vessels
with OCTA and ICGA.
Our findings regarding the morphology of the membrane
are similar to those described by Kuehlewein et al.28 in type 1
CNV. They reported two patterns of vascular complex, the
‘‘medusa-like’’ and the ‘‘sea fan–like’’ complexes, both
characterized by a large main central vessel trunk. This finding
of a feeder vessel has also been investigated by Jia and
associates21 using a prototype of SS-OCT angiography and is
likely a characteristic of more chronic and mature neovascular
complexes associated with chronic PED and longstanding anti-
VEGF therapy.28
We believe that an important clinical application of OCTA is
its ability to noninvasively visualize the extension and
morphology of CNVs in order to follow and potentially predict
the response to anti-VEGF treatment. There are already some
reports describing the neovascular network changes. In
particular, Spaide33 analyzed OCTA images in patients under-
going treatment with anti-VEGF agents. The author describes
CNVs identifiable on OCTA that have large trunks and
prominent peripheral anastomoses. He attributes this to
chronic pruning of small neovascular capillaries by repeated
treatment with anti-VEGF agents, resulting in arteriogenesis of
the remaining vessels.34 Also, Muakkassa et al.34 reported a
decrease of CNV greatest linear dimension and CNV area as
measured on the OCTA angiogram in a small number of
treatment- na¨ıve patients after treatment with intravitreal
bevacizumab.
OCT angiography is a promising imaging modality that will
likely limit the need for invasive FA and ICGA in the setting of
neovascular AMD and may guide evaluation and treatment of
this disorder in the future, although technical limitations are
still considerable and need to be addressed. In particular,
because OCTA technology relies on the detection of blood
flow and movement, any movement by the patient will cause
significant artifact and deterioration of image quality. Projec-
tion artifact is another limitation of this technology, making it
sometimes difficult to distinguish normal physiological vessels
from pathologic ones. The software does provide a ‘‘remove
artifacts’’ function, which can subtract projection artifact from
superficial vessels, but this also causes some loss of signal of
pathologic blood vessels. Finally, not all neovascular complexes
are visualized because of imprecision in slab segmentation,
which requires careful control of the depth and thickness of
the slab to more precisely identify the neovascular membrane.
However, sometimes segmentation to remove choriocapillaris
was not possible using the current automated prototype
software because the user was unable to manually correct the
shape of the automatically detected curvature lines delineating
the region of interest. In the future, adding the ability to
correct the segmentation curvature manually could further
facilitate the accuracy of the AngioVue OCTA software.
Furthermore, because it relies on changes between two
consecutive B-scans, OCTA detects only flow that is higher
than a minimal threshold, the slowest detectable flow, which is
determined by the time between the two sequential OCT B-
scans. Slow-flow lesions that have flow of less than the slowest
detectable flow therefore would not be visualized using this
imaging technique. Increasing the time between consecutive
OCT B-scans could allow for increased flow detection but
would offer a trade-off of increased movement artifact.
In summary, OCT angiography provides the clinician the
ability to perform precise structural and vascular assessment of
CNV noninvasively.
To our knowledge, our study is the largest OCT angiography
analysis to date of neovascular membranes secondary to
neovascular AMD analyzed simultaneously with ICGA and
OCTA. It presents, of course, some limitations. In particular,
the number of PCV and type 3 lesions was too small to perform
statistical analysis. Moreover, the field of ICGA and OCTA
images was different, as well as the software used to measure
the CNV lesion, resulting in an overestimation of the lesion size
with ICGA compared to OCTA.
Future studies with more varied patient demographics and
larger sample sizes for higher-powered sensitivity and speci-
ficity determinations are necessary to evaluate the robustness
of this technique with various types of CNV.
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